Shl Medical
Shl Medical, a leading name in the medical device industry, is headquartered in Switzerland (CH) and operates extensively across Europe and North America. Founded in 1985, the company has established itself as a pioneer in the development and manufacturing of innovative drug delivery systems, particularly in the fields of injectable devices and auto-injectors. Shl Medical's core offerings include advanced pen injectors and wearable delivery systems, distinguished by their user-centric design and precision engineering. With a commitment to quality and safety, the company has achieved significant milestones, including ISO certifications and partnerships with major pharmaceutical firms. Recognised for its expertise and reliability, Shl Medical continues to strengthen its market position, contributing to improved patient outcomes worldwide.
DitchCarbon Score
How does Shl Medical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shl Medical's score of 41 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Shl Medical's reported carbon emissions
In 2023, SHL Medical reported total carbon emissions of approximately 290,355,000 kg CO2e. This figure includes 440,000 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and 43,271,000 kg CO2e from Scope 2 emissions, primarily related to purchased electricity. The majority of their emissions, about 246,644,000 kg CO2e, fall under Scope 3, which encompasses indirect emissions from the value chain, including significant contributions from purchased goods and services (approximately 125,723,000 kg CO2e) and upstream transportation and distribution (about 12,424,000 kg CO2e). Comparatively, in 2022, SHL Medical's total emissions were about 298,110,000 kg CO2e, with Scope 1 emissions at 633,000 kg CO2e and Scope 2 emissions at 42,973,000 kg CO2e. The Scope 3 emissions for that year were approximately 254,504,000 kg CO2e. SHL Medical has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 greenhouse gas emissions by 42% by 2030, using 2022 as the base year. Additionally, they plan to decrease Scope 3 emissions from purchased goods and services, employee commuting, and downstream transportation and distribution by 51.6% per million units sold within the same timeframe. These targets are aligned with the Science Based Targets initiative (SBTi) and are designed to support the global effort to limit warming to 1.5°C. Overall, SHL Medical's emissions data and reduction targets reflect a proactive approach to addressing climate change, with a clear focus on both direct and indirect emissions across their operations.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 633,000 | 000,000 |
| Scope 2 | 42,973,000 | 00,000,000 |
| Scope 3 | 254,504,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shl Medical is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
